name: Gradient compression bandaging supply, bandage liner, upper extremity, any size or length, each


name: Gradient compression bandaging supply, conforming gauze, per linear yard, any width, each


name: Gradient compression bandage roll, elastic long stretch, linear yard, any width, each


name: Gradient compression bandage roll, elastic medium stretch, per linear yard, any width, each


name: Gradient compression bandage roll, inelastic short stretch, per linear yard, any width, each


name: Gradient compression bandaging supply, high density foam sheet, per 250 square centimeters, each


name: Gradient compression bandaging supply, high density foam pad, any size or shape, each


name: Gradient compression bandaging supply, high density foam roll for bandage, per linear yard, any width, each


name: Gradient compression bandaging supply, low density channel foam sheet, per 250 square centimeters, each


name: Gradient compression bandaging supply, low density flat foam sheet, per 250 square centimeters, each


name: Gradient compression bandaging supply, padded foam, per linear yard, any width, each


name: Gradient compression bandaging supply, padded textile, per linear yard, any width, each


name: Gradient compression bandaging supply, tubular protective absorption layer, per linear yard, any width, each


name: Gradient compression bandaging supply, tubular protective absorption padded layer, per linear yard, any width, each


name: Gradient compression bandaging supply, not otherwise specified


name: Gradient compression stocking, below knee, 18-30 mmhg, custom, each


name: Expiratory positive airway pressure intranasal resistance valve


name: Oral mucoadhesive, any type (liquid, gel, paste, etc.), per 1 ml


name: Programmer for transient, orally ingested capsule


name: Programable, transient, orally ingested capsule, for use with external programmer, per month


name: Prescription digital visual therapy, software-only, fda cleared, per course of treatment


name: Enteral feeding supply kit; elastomeric control fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape


name: Catheter, transluminal intravascular lesion preparation device, bladed, sheathed (insertable)


name: Endoscope, single-use (i.e. disposable), pulmonary, imaging/illumination device (insertable)


name: Orthopedic/device/drug matrix/absorbable bone void filler, antimicrobial-eluting (implantable)


name: Retrieval device, insertable, laser (used to retrieve intravascular inferior vena cava filter)


name: Bronchoscopy, rigid or flexible, with bronchial alveolar lavage and transendoscopic endobronchial ultrasound (ebus) during bronchoscopic diagnostic or therapeutic intervention(s) for peripheral lesion(s), including fluoroscopic guidance, when performed


name: Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed and intraprocedural coronary fractional flow reserve (ffr) with 3d functional mapping of color-coded ffr values for the coronary tree, derived from coronary angiogram data, for real-time review and interpretation of possible atherosclerotic stenosis(es) intervention


name: Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed


name: Endoscopic retrograde cholangiopancreatography (ercp) with removal of foreign body(s) or stent(s) from biliary/pancreatic duct(s) and endoscopic cannulation of papilla with direct visualization of pancreatic/common bile duct(s)


name: Debridement, bone (includes epidermis, dermis, subcutaneous tissue, muscle and/or fascia, if performed); first 20 sq cm or less with manual preparation and insertion of drug-delivery device(s), deep (e.g., subfascial)


name: Group psychotherapy service for diagnosis, evaluation, or treatment of a mental health or substance use disorder provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service


name: Gastric restrictive procedure, endoscopic sleeve gastroplasty, with esophagogastroduodenoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components


name: Endoscopic outlet reduction, gastric pouch application, with endoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components


name: Echocardiography image post processing for computer aided detection of heart failure with preserved ejection fraction, including interpretation and report


name: Gastric electrophysiology mapping with simultaneous patient symptom profiling


name: Instillation of anti-neoplastic pharmacologic/biologic agent into renal pelvis, any method, including all imaging guidance, including volumetric measurement if performed


name: Histotripsy (ie, non-thermal ablation via acoustic energy delivery) of malignant renal tissue, including image guidance


name: Magnetic resonance imaging with inhaled hyperpolarized xenon-129 contrast agent, chest, including preparation and administration of agent


name: Blinded or nonblinded procedure for symptomatic new york heart association (nyha) class ii, iii, iva heart failure; transcatheter implantation of left atrial to coronary sinus shunt using jugular vein access, including all imaging necessary to intra procedurally map the coronary sinus for optimal shunt placement (e.g., tee or ice ultrasound, fluoroscopy), performed under general anesthesia in an approved investigational device exemption (ide) study)


name: 3d predictive model generation for pre-planning of a cardiac procedure, using data from cardiac computed tomographic angiography with report


name: Therapeutic radiology simulation-aided field setting; complex, including acquisition of pet and ct imaging data required for radiopharmaceutical-directed radiation therapy treatment planning (i.e., modeling)


name: Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance and real-time positron emissions-based delivery adjustments to 1 or more lesions, entire course not to exceed 5 fractions


name: Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by hardware remote


name: Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by hardware remote, 90-day supply


name: Non-pneumatic sequential compression garment, trunk


name: Upper extremity medical tubing/lines enclosure or covering device, restricts elbow range of motion


name: Virtual reality cognitive behavioral therapy device (cbt), including pre-programmed therapy software


name: Individual counseling for pre-exposure prophylaxis (prep) by physician or qualified health care professional (qhp )to prevent human immunodeficiency virus (hiv), includes hiv risk assessment (initial or continued assessment of risk), hiv risk reduction and medication adherence, 15-30 minutes


name: Injection of pre-exposure prophylaxis (prep) drug for hiv prevention, under skin or into muscle


name: Individual counseling for pre-exposure prophylaxis (prep) by clinical staff to prevent human immunodeficiency virus (hiv), includes: hiv risk assessment (initial or continued assessment of risk), hiv risk reduction and medication adherence


name: Psychotherapy for crisis furnished in an applicable site of service (any place of service at which the non-facility rate for psychotherapy for crisis services applies, other than the office setting); first 60 minutes


name: Psychotherapy for crisis furnished in an applicable site of service (any place of service at which the non-facility rate for psychotherapy for crisis services applies, other than the office setting); each additional 30 minutes (list separately in addition to code for primary service)


name: Community health integration services performed by certified or trained auxiliary personnel, including a community health worker, under the direction of a physician or other practitioner; 60 minutes per calendar month


name: Community health integration services, each additional 30 minutes per calendar month (list separately in addition to g0019)


name: Principal illness navigation services by certified or trained auxiliary personnel under the direction of a physician or other practitioner, including a patient navigator; 60 minutes per calendar month


name: Principal illness navigation services, additional 30 minutes per calendar month (list separately in addition to g0023)


name: Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes


name: Intensive outpatient services; weekly bundle, minimum of 9 services over a 7 contiguous day period, which can include individual and group therapy with physicians or psychologists (or other mental health professionals to the extent authorized under state law); occupational therapy requiring the skills of a qualified occupational therapist; services of social workers, trained psychiatric nurses, and other staff trained to work with psychiatric patients; individualized activity therapies that are not primarily recreational or diversionary; family counseling (the primary purpose of which is treatment of the individual's condition); patient training and education (to the extent that training and educational activities are closely and clearly related to individual's care and treatment); diagnostic services; and such other items and services (excluding meals and transportation) that are reasonable and necessary for the diagnosis or active treatment of the individual's condition, reasonably expected to improve or maintain the individual's condition and functional level and to prevent relapse or hospitalization, and furnished pursuant to such guidelines relating to frequency and duration of services in accordance with a physician certification and plan of treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure


name: Principal illness navigation - peer support by certified or trained auxiliary personnel under the direction of a physician or other practitioner, including a certified peer specialist; 60 minutes per calendar month, in the following activities: person-centered interview, performed to better understand the individual context of the serious, high-risk condition. ++ conducting a person-centered interview to understand the patient's life story, strengths, needs, goals, preferences, and desired outcomes, including understanding cultural and linguistic factors, and including unmet sdoh needs (that are not billed separately). ++ facilitating patient-driven goal setting and establishing an action plan. ++ providing tailored support as needed to accomplish the person-centered goals in the practitioner's treatment plan. identifying or referring patient (and caregiver or family, if applicable) to appropriate supportive services. practitioner, home, and community-based care communication. ++ assist the patient in communicating with their practitioners, home-, and community-based service providers, hospitals, and skilled nursing facilities (or other health care facilities) regarding the patient's psychosocial strengths and needs, goals, preferences, and desired outcomes, including cultural and linguistic factors. ++ facilitating access to community-based social services (e.g., housing, utilities, transportation, food assistance) as needed to address sdoh need(s). health education. helping the patient contextualize health education provided by the patient's treatment team with the patient's individual needs, goals, preferences, and sdoh need(s), and educating the patient (and caregiver if applicable) on how to best participate in medical decision-making. building patient self-advocacy skills, so that the patient can interact with members of the health care team and related community-based services (as needed), in ways that are more likely to promote personalized and effective treatment of their condition. developing and proposing strategies to help meet person-centered treatment goals and supporting the patient in using chosen strategies to reach person-centered treatment goals. facilitating and providing social and emotional support to help the patient cope with the condition, sdoh need(s), and adjust daily routines to better meet person-centered diagnosis and treatment goals. leverage knowledge of the serious, high-risk condition and/or lived experience when applicable to provide support, mentorship, or inspiration to meet treatment goals


name: Principal illness navigation - peer support, additional 30 minutes per calendar month (list separately in addition to g0140)


name: Behavioral counseling for diabetes prevention, in-person, group, 60 minutes


name: Behavioral counseling for diabetes prevention, distance learning, 60 minutes


name: Coordinated specialty care, team-based, for first episode psychosis, per month


name: Coordinated specialty care, team-based, for first episode psychosis, per encounter


name: Molecular diagnostic test reader, nonprescription self-administered and self-collected use, fda approved, authorized or cleared


name: Supplies and accessories (e.g., transducer) for low frequency ultrasonic diathermy treatment device, per month


name: Hip orthosis, bilateral hip joints and thigh cuffs, adjustable flexion, extension, abduction control of hip joint, postoperative hip abduction type, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise


name: Addition to lower extremity prostheses, osseointegrated external prosthetic connector


name: Electrical stimulator supplies (external) for use with implantable neurostimulator, per month


name: Value in primary care mips value pathway


name: Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services


name: Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patient's home; reported only once per individual home per date of service when such vaccine administration(s) are performed at the patient's home


name: Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist or artificial intelligence (ai) interpretation documented and reviewed; with evidence of retinopathy


name: Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist or artificial intelligence (ai) interpretation documented and reviewed; without evidence of retinopathy


name: Cvd risk assessment performed, have a documented calculated risk score


name: Cms medical evidence form 2728 for dialysis patients: initial form completed


name: Receiving esrd mcp dialysis services by the provider on the last day of the reporting month


name: Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop =<25 mm hg for injected eye


name: Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop >25 mm hg and a plan of care was documented


name: Index assessment completed using the 12-item whodas 2.0 or sds during the denominator identification period


name: Suicidal ideation and/or behavior symptoms based on the c-ssrs or equivalent assessment


name: Suicidal ideation and/or behavior symptoms based on the c-ssrs


name: Patient encounter during the performance period with hospice and palliative care specialty code 17


name: Focusing on women's health mips value pathway


name: Quality care for the treatment of ear, nose, and throat disorders mips value pathway


name: Prevention and treatment of infectious disorders including hepatitis c and hiv mips value pathway


name: Quality care in mental health and substance use disorders mips value pathway


name: Rehabilitative support for musculoskeletal care mips value pathway


name: Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription drug, per 30-days


name: Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription drug, per 60-days


name: Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription drug, per 90-days


name: Amniobind or dermabind tl, per square centimeter


name: Woundplus membrane or e-graft, per square centimeter


name: Xcell amnio matrix, per square centimeter


name: Barrera sl or barrera dl, per square centimeter


name: Biovance tri-layer or biovance 3l, per square centimeter


name: Nudyn dl or nudyn dl mesh, per square centimeter


name: Nudyn sl or nudyn slw, per square centimeter


name: Revoshield + amniotic barrier, per square centimeter


name: Membrane wrap-hydro, per square centimeter


name: Amnio tri-core amniotic, per square centimeter


name: Home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem


name: Home injectable therapy, immunotherapy, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem


name: Graft, transmural transvenous arterial bypass (implantable), with all delivery system components


name: Contact lens, hydrophilic, with blue-violet filter, per lens


name: Psychotherapy, Integration, and Navigation Services


name: Oncology (urothelial), mrna expression profiling by real-time quantitative pcr of mdk, hoxa13, cdc2, igfbp5, and cxcr2 in combination with droplet digital pcr (ddpcr) analysis of 6 single-nucleotide polymorphisms (snps) genes tert and fgfr3, urine, algorithm reported as a risk score for urothelial carcinoma


name: Oncology (colorectal) screening, quantitative real-time target and signal amplification of 8 rna markers (gapdh, smad4, acy1, areg, cdh1, kras, tnfrsf10b, egln2) and fecal hemoglobin, algorithm reported as a positive or negative for colorectal cancer risk


name: Oncology (pan-solid tumor), analysis of dna biomarker response to anti-cancer therapy using cell-free circulating dna, biomarker comparison to a previous baseline pre-treatment cell-free circulating dna analysis using next-generation sequencing, algorithm reported as a quantitative change from baseline, including specific alterations, if appropriate


name: Psychiatry (eg, depression, anxiety), genomic analysis panel, including variant analysis of 26 genes, buccal swab, report including metabolizer status and risk of drug toxicity by condition


name: Oncology (prostate), exosome-based analysis of 53 small noncoding rnas (sncrnas) by quantitative reverse transcription polymerase chain reaction (rt-qpcr), urine, reported as no molecular evidence, low-, moderate- or elevated-risk of prostate cancer


name: Genome (eg, unexplained constitutional or heritable disorder or syndrome), rapid sequence analysis, each comparator genome (eg, parents, siblings)


name: Genome (eg, unexplained constitutional or heritable disorder or syndrome), ultra-rapid sequence analysis


name: Monocyte distribution width, whole blood (list separately in addition to code for primary procedure)


name: Oncology (breast), targeted hybrid-capture genomic sequence analysis panel, circulating tumor dna (ctdna) analysis of 56 or more genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability, and tumor mutation burden


name: Human papillomavirus (hpv), oropharyngeal swab, 14 high-risk types (ie, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68)


name: Gastroenterology, malabsorption evaluation of alpha-1-antitrypsin, calprotectin, pancreatic elastase and reducing substances, feces, quantitative


name: Glycine receptor alpha1 igg, serum or cerebrospinal fluid (csf), live cell-binding assay (lcba), qualitative


name: Kelch-like protein 11 (klhl11) antibody, serum or cerebrospinal fluid (csf), cell-binding assay, qualitative


name: Oncology (prostate), 5 dna regulatory markers by quantitative pcr, whole blood, algorithm, including prostate-specific antigen, reported as likelihood of cancer


name: Drug metabolism (adverse drug reactions and drug response), genomic analysis panel, variant analysis of 25 genes with reported phenotypes


name: Oncology, chemotherapeutic drug cytotoxicity assay of cancer stem cells (cscs), from cultured cscs and primary tumor cells, categorical drug response reported based on cytotoxicity percentage observed, minimum of 14 drugs or drug combinations


name: Oncology (lung), plasma analysis of 388 proteins, using aptamer-based proteomics technology, predictive algorithm reported as clinical benefit from immune checkpoint inhibitor therapy


name: Psychiatry (anxiety disorders), mrna, gene expression profiling by rna sequencing of 15 biomarkers, whole blood, algorithm reported as predictive risk score


name: Drug metabolism (adverse drug reactions and drug response), buccal specimen, gene-drug interactions, variant analysis of 33 genes, including deletion/duplication analysis of cyp2d6, including reported phenotypes and impacted gene-drug interactions


name: Administration of respiratory syncytial virus, monoclonal antibody, seasonal dose by intramuscular injection, with counseling by physician or other qualified health care professional


name: Administration of respiratory syncytial virus, monoclonal antibody, seasonal dose by intramuscular injection


name: FDB MedKnowledge (formerly NDDF Plus), 2024_02_14


name: Veterans Health Administration National Drug File, 2024_01_31


name: Metathesaurus FDA Structured Product Labels, 2024_02_24


name: Anatomical Therapeutic Chemical Classification System, 2024_01_19


name: Metathesaurus CMS Formulary Reference File, 2020


name: CarePoint PRECISION 10mL Luer Lock Syringe without Needle


name: CarePoint PRECISION 20mL Luer Lock Syringe without Needle


name: CarePoint PRECISION 30mL Luer Lock Syringe without Needle


name: CarePoint PRECISION 3mL Luer Lock Syringe without Needle


name: CarePoint PRECISION 5mL Luer Lock Syringe without Needle


name: CarePoint PRECISION 60mL Luer Lock Syringe without Needle


name: CarePoint PRECISION 20G 1 inch Poly-Hub Hypodermic Needle


name: Contour Next Link 2.4 Blood Glucose Monitor System


name: Gold Bond Healing Hydration with Aloe Cream


name: CVS Mepilex Border Lite Foam Adhesive Dressing


name: Member's Mark BLULink Glucose Monitoring System


name: Member's Mark BLULink Glucose Test Strip


name: Member's Mark Blood Glucose Monitoring System


name: Unifine PROtect 4mm 32G 5/32 inch Pen Needle


name: Unifine PROtect 5mm 30G 3/16 inch Pen Needle


name: Unifine PROtect 8mm 30G 5/16 inch Pen Needle


name: Vagisil ProHydrate 24+Day Supply Long-Lasting Moisturizing Lubricant


name: Verifine Plus 4mm 32G 5/32 inch Pen Needle & Sharps Container


name: Vicks Speedread Thermometer Fever Insight


name: Vicks Super C Nyquil Liquicaps Nighttime Pack


name: Cleanser Topical application Soap [DAILY FACIAL CLEANSER]


name: Lotion, Multi Ingredient Topical application Lotion [DAILY ULTRA MOISTURE LOTION]


name: Milk/Whey Protein Isolate Oral Suspension [KETOVIE 3:1]


name: OCTINOXATE 5 g in 100 g / ZINC OXIDE 6.2 g in 100 g / OCTOCRYLENE 5 g in 100 g TOPICAL CREAM [Face Sunscreen Skin Care]


name: NIACINAMIDE 1.8 g in 45 mL / ADENOSINE 0.018 g in 45 mL TOPICAL LIQUID [VOVA Scar Serum]


name: ZINC OXIDE 132 mg in 1 mL TOPICAL LOTION [Aspen Islanders Sheer Mineral Sport]


name: ZINC OXIDE 6.2 g in 100 g / OCTINOXATE 5 g in 100 g / OCTOCRYLENE 5 g in 100 g TOPICAL CREAM


name: BENZETHONIUM CHLORIDE 0.0023 mg in 10 mL TOPICAL SOLUTION [Eco Bandage HIBISCUS]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 160 mg in 1 g TOPICAL STICK [Papatui Antiperspirant Deodorant Cedar Sport]


name: NIACINAMIDE 1.8 g in 45 mL / ADENOSINE 0.018 g in 45 mL TOPICAL LIQUID [VOVA Aloe Vera Face Serum]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL LOTION [La Roche Posay Laboratoire Dermatologique Anthelios 60 Face Light Fluid Sunscreen Broad Spectrum SPF 60 Water Resistant 80 Minutes]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 60 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 75 mg in 1 mL TOPICAL CREAM [YSE Beauty Skin Glow SPF 30 Primer]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 95 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 26 mg in 1 mL TOPICAL GEL [SEKKISEI HERBAL UV DEFENSE gel]


name: HOMOSALATE 5 mg in 100 g TOPICAL CREAM [Bulubiu Face Sunscreen SKINCARE]


name: OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 90 mg in 1 mL / HOMOSALATE 73 mg in 1 mL TOPICAL STICK [Hello Sunday The One For Your Lips Clear Lip Balm SPF 50]


name: OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL / HOMOSALATE 70 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL EMULSION [Hello Sunday The Everyday One Face Moisturiser SPF 50]


name: OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 90 mg in 1 mL / HOMOSALATE 70 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL EMULSION [Hello Sunday The One Thats a Serum Hydrating Serum SPF 45]


name: OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 90 mg in 1 mL / HOMOSALATE 73 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL EMULSION [Hello Sunday The Invisible One Sunscreen Plus Primer SPF 50]


name: OCTISALATE 50 mg in 1 mL / TITANIUM DIOXIDE 28 mg in 1 mL / ENSULIZOLE 30 mg in 1 mL TOPICAL CREAM [it cosmetics Your Skin But Better CC Plus Natural Matte Color Correcting Pore Refining Full Coverage Skin Balancing Serum Broad Spectrum SPF 40 Sunscreen]


name: ZINC OXIDE 20 g in 100 g TOPICAL STICK [ATTITUDE Sunly Mineral Sunscreen Stick Unscented SPF 30]


name: ZINC OXIDE 21 g in 100 mL TOPICAL CREAM [THE ENERGIST Multi-Defense Broad Spectrum Sunscreen SPF 50]


name: ZINC OXIDE 35 mg in 1 mL CUTANEOUS CREAM [SUNSCREEN MOISTURIZER]


name: ZINC OXIDE 8 g in 50 mL TOPICAL LOTION [Innisfree Daily UV Defense Mineral Sunscreen]


name: Aluminum Chloride .15 g in 100 mL TOPICAL FOR SOLUTION [Certain Dri Clinical Strength Roll On]


name: NIACINAMIDE 1.8 g in 45 mL / ADENOSINE 0.018 g in 45 mL TOPICAL LIQUID [AnYi Beauty 7 Days Ginger Germinal Oil]


name: ZINC OXIDE 175.2 mg in 1 mL TOPICAL EMULSION [Hello Sunday The Mineral One Lightweight Serum SPF 50]


name: ZINC OXIDE 217.3 mg in 1 g TOPICAL STICK [Hello Sunday The Shimmer One Mineral Glow SPF 45]


name: HOMOSALATE 4.25 g in 100 mL / OCTISALATE 4.75 g in 100 mL / ZINC OXIDE 6.75 g in 100 mL TOPICAL LIQUID [Always Liquid Foundation Makeup Sunscreen Broad Spectrum SPF 15 - Shell]


name: OCTISALATE 4.75 g in 100 mL / HOMOSALATE 4.25 g in 100 mL / ZINC OXIDE 6.75 g in 100 mL TOPICAL LIQUID [Always Liquid Foundation Makeup Sunscreen Broad Spectrum SPF 15 - Natural]


name: OCTISALATE 5 g in 100 mL / HOMOSALATE 15 g in 100 mL / AVOBENZONE 3 g in 100 mL / OCTOCRYLENE 10 g in 100 mL TOPICAL CREAM


name: ZINC OXIDE 24.5 g in 100 g TOPICAL STICK [Botao - Grow Naturally Mineral Sunscreen Clear Facial Stick For Babies and Kids SPF 50]


name: ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 19 g in 100 g TOPICAL CREAM [Old Spice Sweat Defense Captain]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL LOTION [Equate Kids Sunscreen Broad Spectrum SPF 50 Equate]


name: TITANIUM DIOXIDE 1.52 g in 100 g / ZINC OXIDE 9.7 g in 100 g / OCTINOXATE 7 g in 100 g / OCTISALATE 3 g in 100 g TOPICAL CREAM [ELROEL Pang Pang Sun Cushion Plus]


name: MENTHOL 5 g in 100 mL TOPICAL OIL [Mielle Rosemary Mintscalp Hair Strengthening Oil]


name: MINERAL OIL 30 mg in 20 g CUTANEOUS CREAM [scar beuty cream]


name: ZINC OXIDE 15 g in 100 g TOPICAL CREAM [Elta MD UV AOX Eye]


name: OCTINOXATE 7.5 g in 100 mL / OCTISALATE 5 g in 100 mL TOPICAL LOTION [Vivant Day Treatment SPF 15]


name: OCTISALATE 10 mg in 1 g / OXYBENZONE 10 mg in 1 g / OCTINOXATE 65 mg in 1 g TOPICAL LOTION [Arizona Sun Sunscreen SPF 8]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 10 g in 100 g TOPICAL STICK [Olay Glow plus Protect Sunscreen Dewy Glow SPF 50]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 9 g in 100 mL / OCTISALATE 4.5 g in 100 mL / OCTOCRYLENE 8.5 g in 100 mL TOPICAL LOTION [OLAY Prime plus Protect Facial Sunscreen with Vitamin C SPF35 Matte Finish]


name: HYDROQUINONE 2 g in 100 mL TOPICAL CREAM [Vivant True Tone]


name: HYDROQUINONE 2 g in 100 mL TOPICAL GEL [Vivant True Tone Forte]


name: NIACINAMIDE 0.1 g in 88 g / .ALPHA.-TOCOPHEROL ACETATE 0.5 g in 88 g / TITANIUM DIOXIDE 0.1 g in 88 g / ZINC OXIDE 0.1 g in 88 g TOPICAL LOTION


name: SALICYLIC ACID 1.5 g in 50 g / HYALURONATE SODIUM 0.05 g in 50 g / NIACINAMIDE 2 g in 50 g / ZINC GLUCONATE 0.5 g in 50 g / MENTHOL 0.03 g in 50 g TOPICAL CREAM


name: TEA TREE OIL 5 g in 100 mL / HONEY 3 g in 100 mL / 1,3-BIS(BENZOTHIAZOL-2-YLTHIOMETHYL)UREA 10 g in 100 mL TOPICAL LINIMENT [HydraHeal Foot Cream]


name: ZINC OXIDE 15.52 g in 50 mL TOPICAL CREAM [THE FACE SHOP EVERYDAY MINERAL FACE PROTECTION SPF 50]


name: HYALURONIC ACID 3 g in 100 mL / POMEGRANATE 10 g in 100 mL / PODOCORYNA CARNEA FIBRILLAR COLLAGEN 2 g in 100 mL / SQUALANE 2 g in 100 mL TOPICAL LOTION [Eclipse Anti-Aging Eye Balm]


name: AVOBENZONE 3 g in 100 g / OCTISALATE 5 g in 100 g / HOMOSALATE 10 g in 100 g TOPICAL PASTE [SPF 25 LIP BALM]


name: OCTINOXATE 75 mg in 1 g / OCTISALATE 30 mg in 1 g / AVOBENZONE 20 mg in 1 g / OXYBENZONE 30 mg in 1 g TOPICAL LOTION [Arizona Sun Sunscreen SPF15]


name: AVOBENZONE 3 g in 100 mL / OCTOCRYLENE 6 g in 100 mL / HOMOSALATE 10 g in 100 mL TOPICAL LOTION [Death Tan SPF 50 Sport Sunscreen]


name: OCTINOXATE 75 mg in 1 mL / TITANIUM DIOXIDE 15 mg in 1 mL TOPICAL CREAM [REPAIRWEAR LASER FOCUS SPF 15 LINE SMOOTHING CO/O]


name: OCTOCRYLENE 2 g in 100 mL / OCTISALATE 5 g in 100 mL / ZINC OXIDE 8.4 g in 100 mL TOPICAL LOTION [Weightless Protection SPF 45]


name: Zinc Oxide 20 g in 100 mL TOPICAL CREAM [SHEER MINERAL SUNSCREEN]


name: Estrone 1 g in 1 g NOT APPLICABLE POWDER


name: AVOBENZONE 30 mg in 1 g / OCTISALATE 50 mg in 1 g / HOMOSALATE 50 mg in 1 g / OXYBENZONE 30 mg in 1 g / OCTINOXATE 75 mg in 1 g TOPICAL LOTION [Arizona Sun Sunscreen SPF 30]


name: HOMOSALATE 50 mg in 1 g / OCTINOXATE 75 mg in 1 g / AVOBENZONE 30 mg in 1 g / OCTISALATE 50 mg in 1 g / OXYBENZONE 30 mg in 1 g TOPICAL LOTION [Arizona Sun Sunscreen Water Resistant SPF 30]


name: OCTINOXATE 6 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 10 g in 100 mL / AVOBENZONE 3 g in 100 mL / HOMOSALATE 5 g in 100 mL TOPICAL LOTION [ALOE UP PRO SPF 50 ADVANCED FORMULA ULTRA SPORT SUNSCREEN]


name: OCTISALATE 50 mg in 1 g / HOMOSALATE 50 mg in 1 g / OCTINOXATE 75 mg in 1 g / OXYBENZONE 30 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL LOTION [Arizona Sun Kids Sunscreen SPF 30]


name: OXYBENZONE 2 g in 100 mL / OCTINOXATE 2 g in 100 mL TOPICAL SPRAY [ALOE UP DARK TANNING OIL SPF 4 CONTINUOUS SUNSCREEN]


name: AMINOCAPROIC ACID 1 g in 1 g NOT APPLICABLE POWDER [aminocaproid acid]


name: AVOBENZONE 2.2 g in 100 mL / HOMOSALATE 7 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 5 g in 100 mL TOPICAL GEL [Multi Vitamin Clear Coat Broad Spectrum SPF 50]


name: TITANIUM DIOXIDE 60 mg in 1 g / HOMOSALATE 50 mg in 1 g / OCTISALATE 45 mg in 1 g / OCTOCRYLENE 30 mg in 1 g / ZINC OXIDE 63 mg in 1 g TOPICAL CREAM [e l f Camo Semi Matte CC SPF 30 Rich 620 W]


name: ZINC OXIDE 100 mg in 1 mL TOPICAL CREAM [e l f Sun Boss Gloss SPF 25 Sunscreen Its your Mauve]


name: ZINC OXIDE 63 mg in 1 g / TITANIUM DIOXIDE 60 mg in 1 g / HOMOSALATE 50 mg in 1 g / OCTISALATE 45 mg in 1 g / OCTOCRYLENE 30 mg in 1 g TOPICAL CREAM [e l f Camo Semi Matte CC SPF 30 Deep 530 W]


name: ALLANTOIN 0.5 g in 100 mL TOPICAL GEL [THE MAN BY VANIBISS RAZOR BUMPS SERUM]


name: DIMETHICONE 12 h TOPICAL PATCH [RevivaSil]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 7 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 10 g in 100 mL TOPICAL CREAM [JAFRA SKIN Glow Face Cream Broad Spectrum SPF 15 Sunscreen]


name: OCTISALATE 50 mg in 1 g TOPICAL OIL [Arizona Sun Tanning Oil SPF 3]


name: RACTOPAMINE HYDROCHLORIDE 1 kg in 1 kg NOT APPLICABLE SUSPENSION


name: ZINC OXIDE 150 mg in 1 mL TOPICAL LIQUID [MIAMI BEACH BUM SPF-50 Blocked Sunscreen]


name: ZINC OXIDE 20 g in 100 g TOPICAL STICK [ATTITUDE Oatmeal Sensitive Natural Mineral Sunscreen Face Stick Unscented SPF 30]


name: OCTOCRYLENE 4 g in 50 mL / ZINC OXIDE 8.73 g in 50 mL / OCTISALATE 2.5 g in 50 mL / TITANIUM DIOXIDE 1.53 g in 50 mL TOPICAL CREAM [GANGNAM Glow Day Shield Perfect Sunscreen SPF 50]


name: OCTINOXATE 75 mg in 1 g / OCTISALATE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g / OXYBENZONE 30 mg in 1 g / HOMOSALATE 50 mg in 1 g TOPICAL LOTION [Arizona Sun Sunscreen Kids Water Resistant SPF 30]


name: OCTISALATE 4.5 g in 50 mL / HOMOSALATE 9 g in 50 mL / AVOBENZONE 2.7 g in 50 mL / OCTOCRYLENE 9 g in 50 mL TOPICAL CREAM [CNP Laboratory Sun Care Milky Light Sunscreen Broad Spectrum SPF 50]


name: POLYSILICONE-15 5 g in 100 g / OCTOCRYLENE 5 g in 100 g / OCTINOXATE 7 g in 100 g / HOMOSALATE 6 g in 100 g / AVOBENZONE 2 g in 100 g TOPICAL LIPSTICK [SUNSCREEN LIP BALM]


name: VITAMIN A 0.01 g in 100 g TOPICAL CLOTH [SKINEEZ]


name: ZINC OXIDE 10 g in 100 g TOPICAL STICK [ATTITUDE Sunly Lip balm Unscented SPF 15]


name: GLYCOLIC ACID 1 g in 100 mg / ASCORBIC ACID 2 g in 100 mg / NIACINAMIDE 3 g in 100 mg / KOJIC ACID 2 g in 100 mg / ARBUTIN 2 g in 100 mg TOPICAL SOAP [kojic acid]


name: ASCORBIC ACID 10 mg in 100 mL TOPICAL LIQUID [Vitamin C 10 %]


name: ASCORBIC ACID 15 mg in 100 mL TOPICAL LIQUID [Vitamin C 15 %]


name: CAFFEINE 4 mg in 100 g / CAPSICUM SPP. 2 mg in 100 g / GRAPEFRUIT OIL 1 mg in 100 g TOPICAL LOTION [VelvetTouch Luxe Body Cream]


name: NIACINAMIDE 2 mg in 100 mL TOPICAL SOLUTION [Bliss Republic Dark Spot Wand]


name: OCTINOXATE 1.995 g in 100 g TOPICAL POWDER [GOLDEN ROSE CORRECT AND CONCEAL Concealer Cream Palette]


name: OCTINOXATE 15 mg in 1 g / OXYBENZONE 5 mg in 1 g TOPICAL LOTION [Arizona Sun Moisturizer SPF 3]


name: PANTHENOL 10 mg in 100 g / HAIR KERATIN AMINO ACIDS 15 mg in 100 g / NIACINAMIDE 10 mg in 100 g / BIOTIN 15 mg in 100 g / ROSEMARY 20 mg in 100 g TOPICAL LIQUID


name: STURGEON, UNSPECIFIED 97.5 g in 100 mL TOPICAL GEL [The Zoeun Skin Sturgeon Gel]


name: TEA TREE OIL 3 mg in 100 g / KOJIC ACID 2 mg in 100 g TOPICAL SOAP [GlowBright Radiance Bar]


name: HOMOSALATE 40 mg in 1 mL / OCTOCRYLENE 40 mg in 1 mL / OXYBENZONE 15 mg in 1 mL / TITANIUM DIOXIDE 103 mg in 1 mL TOPICAL CREAM [CLARINS UV PLUS ANTI-POLLUTION SUNSCREEN MULTI-PROTECTION BROAD SPECTRUM SPF 50 Oil-Free -DEEP]


name: HYALURONIC ACID 6 mg in 100 g / RETINYL RETINOATE 12 mg in 100 g / CAFFEINE 4 mg in 100 g TOPICAL LOTION [Natural Firming Belly Cream]


name: HYALURONIC ACID 3 mg in 100 g / ELASTIN (HUMAN) 1 mg in 100 g TOPICAL LOTION [COLLAGEN RETINOL HYALURONIC ACID]


name: OCTISALATE 50 mg in 1 g / OXYBENZONE 50 mg in 1 g / OCTOCRYLENE 70 mg in 1 g / AVOBENZONE 30 mg in 1 g / OCTINOXATE 75 mg in 1 g / HOMOSALATE 100 mg in 1 g TOPICAL SPRAY [Arizona Sun SPF 45 Bikerblok Sunscreen]


name: OCTOCRYLENE 70 mg in 1 g / AVOBENZONE 30 mg in 1 g / OCTINOXATE 75 mg in 1 g / OCTISALATE 50 mg in 1 g / HOMOSALATE 100 mg in 1 g / OXYBENZONE 50 mg in 1 g TOPICAL SPRAY [Arizona Sun SPF 45 Surfblok Sunscreen]


name: HOMOSALATE 100 mg in 1 g / OCTOCRYLENE 70 mg in 1 g / OCTISALATE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g / OCTINOXATE 75 mg in 1 g / OXYBENZONE 50 mg in 1 g TOPICAL SPRAY [Arizona Sun SPF 45 Golfblok Sunscreen]


name: FLURALANER 1 kg in 1 kg NOT APPLICABLE POWDER


name: eye drop administration aid MISCELL EACH


name: bitter mask flavor combination no.4 MISCELL POWDER (GRAM)


name: diluent for Haemophilus b vaccine (tetanus-conj)(0.9 % NaCl) 0.9 % INTRAMUSC SYRINGE (ML)


name: gelatin troche base no.265 MISCELL GEL (GRAM)


name: lactose-reduced food 0.07 gram-1.5 kcal/mL ORAL LIQUID (ML)


name: powder base no.266 MISCELL POWDER (GRAM)


name: sunflower/olive/beeswax/coconut/shea butter/marigold/argan TOPICAL OINTMENT (GRAM)


name: vehicle gel for anacaulase-bcdb TOPICAL GEL (GRAM)


name: CATHETER,SELF-CATH COUDE 16FR COLOPLAST #816


name: DRESSING,REINFORCED GELLING FIBERS + AG 18IN ROPE


name: CAPSAICIN 0.025% CREAM/DICLOFENAC NA 2% SOLUTION KIT


name: HYALURONATE NA (BARRIGEL) 20MG/ML INJ,SYRINGE,3ML


name: DRESSING,ADAPTIC TOUCH NON-ADHERING SILICONE 8IN X 12.25IN


name: DRESSING,ADAPTIC TOUCH NON-ADHERING SILICONE 3IN X 4.25IN


name: BAG,ENTERAL DRAINAGE SET ENFIT #VED-012EO


name: STOMA CAPTURE CARTRIDGE STOMAGIENICS #12016


name: POUCH,DRAINABLE,HIGH OUTPUT FLEXTEND H#26064


name: CATHETER,SELF-CATH SOFT 12FR COLOPLAST #50181


name: CATHETER,SELF-CATH SOFT 14FR COLOPLAST #50182


name: CATHETER,SELF-CATH SOFT 16FR COLOPLAST #50183


name: DRESSING,MEDIHONEY HYDROGEL 4.3IN X 4.3IN


name: Provision of written information about cardiomyopathy


name: Provision of written information about prescribed diet


name: Provision of written information about breastfeeding


name: Provision of written information about weight management


name: Assessment using Asthma Therapy Assessment Questionnaire for children and adolescents


name: Assessment using Asthma Therapy Assessment Questionnaire Adult


name: Referral to transportation fuel voucher program


name: Assistance with application for transportation fuel voucher program


name: Evaluation of eligibility for transportation fuel voucher program


name: Education about transportation fuel voucher program


name: Provision of transportation fuel voucher


name: Assistance with application for child financial support


name: Evaluation of eligibility for Department of Veterans Affairs Veterans Benefits Program


name: Assistance with application for Department of Veterans Affairs Veterans Benefits Program


name: Education about transportation support program


name: Evaluation of eligibility for transportation support program


name: Referral to transportation support program


name: Assistance with application for residential abatement program


name: Assistance with application for socially assistive robots program


name: Assistance with application for Unemployment Insurance Program


name: Assistance with filing request for order of protection


name: Education about library educational programs


name: Education about National Immigration Law Center


name: Education about residential abatement program


name: Education about StrongHearts Native Helpline


name: Education about violence recovery program


name: Evaluation of eligibility for Day Shelter Program


name: Evaluation of eligibility for residential abatement program


name: Provision of educational materials voucher


name: Referral to National Immigration Law Center


name: Referral to residential abatement program


name: Hospital-based cardiac catheterization laboratory


name: Surveillance Epidemiology and End Results Program, Extent of Disease - 2018 edition


name: Provision of written information about smokeless tobacco cessation


name: Provision of written information about second hand smoke exposure


name: Provision of written information about nutrition while breast feeding


name: Provision of written information about nutrition


name: Provision of written information about natural family planning


name: Provision of written information about hypertension


name: Provision of written information about emergency contraception


name: Provision of written information about Dietary Approaches to Stop Hypertension


name: Provision of written information about contraception


name: Provision of written information about cholesterol management


name: Provision of written information about body mass index


name: Provision of written information about blood pressure measurement


name: Provision of written information about bariatric surgery


name: Provision of written information about alcohol withdrawal


name: Provision of written information about alcohol intoxication


name: Provision of written information about alcohol consumption


name: Provision of written information about alcohol abuse


name: Provision of pediatric asthma action plan


name: Provision of written information about preventing spread of disease caused by severe acute respiratory syndrome coronavirus 2


name: Provision of written information about disease caused by severe acute respiratory syndrome coronavirus 2


name: Education toward completion of learning objectives of early-college high school program


name: Education toward completion of learning objectives of high school completion program


name: Education toward completion of learning objectives of General Educational Development Program


name: SNOMEDCT_US_2024_03_01 to ICD10CM_2024 Mappings


name: SNOMEDCT_US_2024_03_01 to ICD10_2016 Mappings


name: Kletsel Dehe Wintun Nation of the Cortina Rancheria


name: Coagulation surface induced.lupus sensitive.buffer (LA control)


name: Lupus anticoagulant aPTT screening panel


name: Cells.chromosome Y deletion/Cells counted


name: Cells.chromosome region 1p32 deletion/Cells counted


name: Cells.chromosome region 20q12 deletion/Cells counted


name: Hereditary motor neuropathy multigene analysis


name: Hereditary motor and sensory neuropathy multigene analysis


name: Hereditary sensory neuropathy multigene analysis


name: Hereditary spastic paraplegia multigene analysis


name: Hereditary congenital myasthenic syndrome multigene analysis


name: Hereditary emery dreifuss multigene analysis


name: Dyserythropoietic anemia multigene analysis


name: Erythrocytosis focused multigene analysis


name: CYB5 and CYB5 Reductase multigene analysis


name: EBV Lymphoproliferation multigene analysis


name: Dysregulation autoimmune multigene analysis


name: Autoimmune lymphoproliferative syndrome multigene analysis


name: Bacteria Identification and Susceptibilty


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 5.1


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 5.1


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 5.1


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 5.1


name: Peripheral neuropathy multigene analysis


name: Information to tell doctors if you have a sudden injury or illness with a good chance of recovery


name: Information to tell the medical team if you stop breathing or your heart stops beating


name: CMS - Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 4.2


name: IRF-PAI v4.2, LCDS v5.1, MDS v1.19.1 - Functional abilities - admission


name: IRF-PAI v4.2, LCDS v5.1, MDS v1.19.1 - Functional abilities - discharge


name: Multisection for pregnancy+third trimester


name: Information to tell doctors if you experience failing health with a low chance of recovery


name: Multisection for pregnancy+second trimester


name: HISGT Histone genes targeted mutation analysis


name: Multiple sulfatase deficiency enzymes panel


name: Basic metabolic & hemoglobin & hematocrit panel


name: Cosmetic facility registration-abbreviated renewal


name: Cosmetic facility registration-biennial renewal


name: Breast Cancer recurrence risk multigene analysis


name: Feeling down, depressed, irritable, or hopeless in last 2W


name: Poor appetite, weight loss, or overeating in last 2W


name: Trouble concentrating on things like school work, reading, or watching TV in last 2W


name: Mucopolysaccharidosis type II newborn screen interpretation


name: Guanidinoacetate methyltransferase deficiency comment


name: Medication list for public health &or CDC reporting


name: Diagnostic multisection transesophageal & cardioversion panel


name: Multisection transesophageal for congenital disease


name: Views screening for diabetic retinopathy


name: Duration description of condition episode


name: Chronic and low grade B cell lymphoid neoplasm multigene analysis


name: B cell non hodgkin Lymphoma multigene analysis


name: Diagnostic peripheral vascular disease study


name: Oxalate & Glycolate & Glyoxylate & Citrate:Imp:Pt:Urine:Nom


name: Escherichia coli O157:H7 DNA:PrThr:Pt:Wound:Ord:Probe.amp.tar


name: PLA2G7 & PLAC8 gene expression level:Score:Pt:Bld:Qn:Molgen


name: SARS coronavirus 2 Mpro gene mutation detected:Prid:Pt:XXX:Nom:Molgen


name: HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA+Hepatitis E virus RNA:PrThr:Pt:Ser/Plas/Bld^Donor:Ord:Probe.amp.tar


name: AAV serotype rh74 Ab:PrThr:Pt:Ser/Plas:Ord:IA


name: Direct antiglobulin test.polyspecific reagent:PrThr:Pt:RBC^Fetus:Ord


name: Staphylococcus aureus MLVA type:Type:Pt:Isolate/Specimen:Nom:Molgen


name: Imatinib ^24H post dose:MCnc:Pt:Ser/Plas:Qn:LC/MS/MS


name: N-Desethyl Sunitinib^24H post dose:MCnc:Pt:Ser/Plas:Qn:LC/MS/MS


name: Hepatitis B virus RNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Coagulation surface induced.lupus sensitive.buffer (LA control):Time:Pt:PPP:Qn:Coag


name: Lupus anticoagulant aPTT screening panel:-:Pt:PPP:-:Coag


name: Small lymphocytic lymphoma chromosome deletions &or rearrangements:Find:Pt:Bld/Tiss:Doc:FISH


name: Enterococcus faecalis+Enterococcus faecium DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Klebsiella pneumoniae oxytoca DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis:PrThr:Pt:Genital fld:Ord:Probe.amp.tar


name: Coccidioides sp Ab.IgG & IgM:ACnc:Pt:Ser+CSF:Ord:IA


name: Herpes virus 6A DNA:NCnc:Pt:Ser/Plas:Qn:Non-probe.amp.tar


name: Herpes virus 6B DNA:ACnc:Pt:Ser/Plas:Qn:Non-probe.amp.tar


name: Cortisol^2H post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: Lutropin^10M post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Lutropin^4H post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Cells.chromosome Y deletion/Cells counted:NFr:Pt:Bld/Bone mar:Qn:FISH


name: Campylobacter & Salmonella & Shigella sp identified:Prid:Pt:Stool:Nom:Organism specific culture


name: Campylobacter & Salmonella & Shigella & Yersinia sp identified:Prid:Pt:Stool:Nom:Organism specific culture


name: Salmonella & Shigella & Campylobacter & E. coli sp identified:Prid:Pt:Stool:Nom:Organism specific culture


name: Cells.CD200/100 cells:NFr:Pt:Bone marrow:Qn:Flow cytometry


name: Cells.chromosome region 1p32 deletion/Cells counted:NFr:Pt:Bld/Bone mar:Qn:FISH


name: Cells.chromosome region 1q21 duplication:NFr:Pt:Bld/Bone mar:Qn:FISH


name: Soluble triggering receptor expressed on myeloid cells-1:MCnc:Pt:Ser/Plas:Qn:IA


name: Hemiplegic migraine multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: CTNNB1 gene targeted mutation analysis:Find:Pt:Tumor:Doc:Molgen


name: TP53 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Gamma aminobutyrate A receptor Ab.IgG:PrThr:Pt:CSF:Ord:CBA IFA


name: Crimean-Congo hemorrhagic fever virus RNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Ebolavirus Bundibugyo+Reston+Sudan+Taï Forest+Zaire RNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: West Nile virus RNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Yellow fever virus RNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Cells.chromosome region 20q12 deletion/Cells counted:NFr:Pt:Bld/Bone mar:Qn:FISH


name: Hereditary motor neuropathy multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hereditary motor and sensory neuropathy multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hereditary sensory neuropathy multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hereditary spastic paraplegia multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Distal weakness multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hereditary congenital myasthenic syndrome multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hereditary emery dreifuss multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Dyserythropoietic anemia multigene analysis:Find:Pt:XXX:Doc:Sequencing


name: CYB5 and CYB5 Reductase multigene analysis:Find:Pt:XXX:Doc:Sequencing


name: RBC membrane multigene analysis:Find:Pt:XXX:Doc:Sequencing


name: EBV Lymphoproliferation multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hyper igE syndrome multigene analysis:Find:Pt:XXX:Doc:Molgen


name: Dysregulation autoimmune multigene analysis:Find:Pt:XXX:Doc:Molgen


name: Viral Susceptibility multigene analysis:Find:Pt:XXX:Doc:Molgen


name: Autoimmune lymphoproliferative syndrome multigene analysis:Find:Pt:XXX:Doc:Molgen


name: Other cells/100 leukocytes:NFr:Pt:BAL:Qn:Manual count


name: Human papilloma virus 16 & 18+45 mRNA:PrThr:Pt:Anorectal:Ord:Probe.amp.tar


name: Chemokine (C-C motif) ligand 26:MCnc:Pt:Ser/Plas:Qn:IA


name: Monocyte Chemoattractant Proteins 4 (MCP-4/CCL13):MCnc:Pt:Ser/Plas:Qn:IA


name: Influenza A H3N2V RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Bacteria Identification and Susceptibilty:Find:Pt:Bld.pos growth:Doc


name: Aeromonas & plesiomonas sp identified:Prid:Pt:Stool:Nom:Organism specific culture


name: Renal calculus risk assessment:Likelihood:24H:Urine:Nar


name: Tripartite motif containing 46:PrThr:Pt:XXX:Ord:IF


name: HBA1 & HBA2 gene deletion:Find:Pt:Amnio fld/CVS:Doc:Molgen


name: NOTCH3 gene full mutation analysis:Find:Pt:XXX:Doc:Molgen


name: Motor neuron disease multigene analysis:Find:Pt:XXX:Doc:Molgen


name: Muscular dystrophy multigene analysis:Find:Pt:XXX:Doc:Molgen


name: HIF2A gene targeted mutation analysis:Find:Pt:Bld:Doc:Molgen


name: Peripheral neuropathy multigene analysis:Find:Pt:XXX:Doc:Molgen


name: KRAS Somatic mutation analysis:Find:Pt:Tumor:Doc:Molgen


name: Parkinson Disease multigene analysis:Find:Pt:XXX:Doc:Molgen


name: HISGT Histone genes targeted mutation analysis:Find:Pt:Tumor:Doc:Molgen


name: Multiple sulfatase deficiency enzymes panel:-:Pt:WBC:-


name: Basic metabolic & hemoglobin & hematocrit panel:-:Pt:Bld:-


name: Human bocavirus DNA:PrThr:Pt:Respiratory system specimen.upper:Ord:Non-probe.amp.tar


name: Legionella pneumophila DNA:PrThr:Pt:Respiratory system specimen.upper:Ord:Non-probe.amp.tar


name: Cells.CD34 recipient derived/Cells.CD34^post stem cell transplantation:NFr:Pt:Bone mar:Qn:Molgen


name: Breast Cancer recurrence risk multigene analysis:PrThr:Pt:Tissue:Ord:Molgen


name: Cytokeratin 19 mRNA for cancer metastasis:PrThr:Pt:Lymph node:Ord:Non-probe.amp.tar


name: TRCA+TCRD gene rearrangements:Find:Pt:Bone marrow:Doc:FISH


name: TCL-1A gene rearrangements:Find:Pt:Bone marrow:Doc:FISH


name: Human papilloma virus 31+33+52+58 DNA:PrThr:Pt:Cvx:Ord:Probe.amp.tar


name: Clostridium tetani toxin TeNT gene:PrThr:Pt:XXX:Ord:Non-probe.amp.tar


name: Clostridium tetani toxin TeNT gene:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Clostridium tetani toxin:PrThr:Pt:XXX:Ord:Mouse bioassay.neutralization


name: Clostridium tetani toxin:PrThr:Pt:XXX:Ord:Endopeptidase Assay


name: Clostridium tetani toxin:PrThr:Pt:Ser/Plas:Ord:Endopeptidase Assay


name: Clostridium tetani toxin:PrThr:Pt:Ser/Plas:Ord:Mouse bioassay


name: Mucopolysaccharidosis type II newborn screen interpretation:Imp:Pt:Bld.dot:Nom


name: Mucopolysaccharidosis type II comment:Txt:Pt:Bld.dot:Nar


name: Guanidinoacetate methyltransferase deficiency comment:Txt:Pt:Bld.dot:Nar


name: Immunoglobulin lambda light chain gene 22q11.22 rearrangement:Find:Pt:XXX:Doc:FISH


name: Immunoglobulin kappa light chain gene 2p11.2 rearrangement:Find:Pt:XXX:Doc:FISH


name: CRLF2 gene rearrangements:Find:Pt:Bld/Bone mar:Doc:FISH


name: Chronic and low grade B cell lymphoid neoplasm multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: B cell non hodgkin Lymphoma multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Histiocytic neoplasm multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Plasma cell myeloma multigene analysis:Find:Pt:Bone marrow:Doc:Molgen


name: T cell lymphoma multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Platelet aggregation.adenosine diphosphate induced ATP secretion^2 umol/L:RelACnc:Pt:Bld:Qn


name: Platelet aggregation.collagen induced^2 ug/mL:RelACnc:Pt:PRP:Qn


name: Fibroblast growth factor 23:PrThr:Pt:Tissue:Ord:FISH


name: Hepatitis A virus cellular receptor 1:Ratio:Pt:Urine:Qn:Calculation


name: IgH & IgK gene rearrangement status:Prid:Pt:XXX:Nom:Molgen


name: Hematopoietic progenitor cells/cells.total:NFr:Pt:Bld:Qn:Automated count


name: ALK gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: MET gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: BRAF gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: ERBB2 gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Chromosome 5 & 9 & 15 aneuploidy:Find:Pt:Bone mar:Doc:FISH


name: ROS1 gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: KIT gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: PDGFRA gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: PDGFRA gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Common myeloid progenitor cell:NCnc:Pt:Bld:Qn:VC


name: Common myeloid progenitor cell:NCnt:Pt:Bld:Qn


name: Burst forming unit erythroid:NCnc:Pt:Bld:Qn:VC


name: Burst forming unit erythroid:NCnt:Pt:Bld:Qn


name: CXCR4 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Bacillus anthracis Ab^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Bacillus anthracis Ab^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Bacillus anthracis protective antigen Ab:PrThr:Pt:Ser:Ord:IA


name: Bordetella pertussis Ab.IgA^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Bordetella pertussis Ab.IgA^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Bordetella pertussis.pertussis toxin Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Bordetella pertussis.pertussis toxin Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Borna disease virus RNA:PrThr:Pt:Brain tissue:Ord:Probe.amp.tar


name: Borna disease virus RNA:PrThr:Pt:Brain tissue:Ord:Probe


name: Borna disease virus RNA:PrThr:Pt:Brain tissue:Ord:Sequencing


name: Borna disease virus RNA:PrThr:Pt:CSF:Ord:Probe.amp.tar


name: Borna disease virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Borna disease virus:PrThr:Pt:XXX:Ord:Organism specific culture


name: Borna disease virus RNA:PrThr:Pt:XXX:Ord:Sequencing


name: Borna disease virus Ag:PrThr:Pt:Brain tissue:Ord:Immune stain


name: Borna disease virus Ag:PrThr:Pt:XXX:Ord:Immune stain


name: Borrelia recurrentis:PrThr:Pt:CSF:Ord:Organism specific culture


name: Borrelia recurrentis:PrThr:Pt:Bld:Ord:Organism specific culture


name: Brucella sp Ab^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Brucella sp Ab^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Chikungunya virus Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Chlamydophila psittaci Ab^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Chlamydophila psittaci Ab^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Corynebacterium pseudotuberculosis:PrThr:Pt:XXX:Ord:Organism specific culture


name: Corynebacterium pseudotuberculosis:PrThr:Pt:Respiratory system specimen.upper:Ord:Organism specific culture


name: Corynebacterium ulcerans:PrThr:Pt:Respiratory system specimen.upper:Ord:Organism specific culture


name: Coxiella burnetii Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Coxiella burnetii Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Coxiella burnetii Ab.IgM^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Coxiella burnetii Ab.IgM^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Dengue virus Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Dengue virus Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Dengue virus Ab.IgM^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Ebola virus Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Ebola virus Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: European tick borne encephalitis virus Ab.IgA index:ACnc:Pt:Ser+CSF:Qn


name: European tick borne encephalitis virus Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: European tick borne encephalitis virus Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: European tick borne encephalitis virus Ab.IgM:Titr:Pt:CSF:SemiQn:IA


name: European tick borne encephalitis virus Ab.IgM:Titr:Pt:Ser:SemiQn:IA


name: European tick borne encephalitis virus RNA:PrThr:Pt:CSF:Ord:Probe.amp.tar


name: European tick borne encephalitis virus RNA:PrThr:Pt:Tissue.postmortem:Ord:Probe.amp.tar


name: Francisella tularensis Ab^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Francisella tularensis Ab^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Hepatitis A virus Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Hepatitis A virus Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Hepatitis A virus Ab.IgM:Titr:Pt:Ser:SemiQn


name: Hepatitis E virus Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Hepatitis E virus Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Lassa virus Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Lassa virus Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Legionella sp Ab^1st specimen:Titr:Pt:Ser:Ord:IA


name: Leptospira sp Ab^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Leptospira sp Ab.IgM^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Leptospira sp Ab.IgM^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Measles virus Ab.IgG avidity:Ratio:Pt:Ser:SemiQn:IA


name: Middle East respiratory syndrome coronavirus:PrThr:Pt:XXX:Ord:Neut


name: Mycobacterium leprae anti-PGL-1 Ab:Titr:Pt:Ser:SemiQn


name: Norovirus genogroup II Ag:PrThr:Pt:Stool:Ord


name: Polio virus 1 Ab^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Polio virus 1 Ab^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Polio virus 3 Ab^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Polio virus 3 Ab^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Rickettsia prowazekii Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Rickettsia prowazekii Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Rubella virus Ab.IgM index:ACnc:Pt:Ser+CSF:Qn


name: SARS coronavirus 2 RNA:PrThr:Pt:Respiratory System Specimen:Ord


name: Trichinella spiralis Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Trichinella spiralis Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Varicella zoster virus Ab.IgA index:ACnc:Pt:Ser+CSF:Qn


name: Varicella zoster virus Ab.IgA:PrThr:Pt:CSF:Ord:IA


name: Varicella zoster virus Ab.IgG:PrThr:Pt:CSF:Ord:IA


name: Yellow fever virus Ab.IgG:Titr:Pt:Ser:SemiQn:IA


name: Yellow fever virus Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Yersinia enterocolitica O:3 Ab:PrThr:Pt:Stool:Ord


name: Yersinia enterocolitica O:5 Ab:PrThr:Pt:Stool:Ord


name: Yersinia enterocolitica O:8 Ab:PrThr:Pt:Stool:Ord


name: Yersinia enterocolitica O:9 Ab:PrThr:Pt:Stool:Ord


name: Yersinia pestis Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Yersinia pestis Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Yersinia pseudotuberculosis 2 Ab:PrThr:Pt:Stool:Ord


name: Yersinia pseudotuberculosis 3 Ab:PrThr:Pt:Stool:Ord


name: Zika virus Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Zika virus Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Follitropin^4H post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Erythrocytosis focused multigene analysis:Find:Pt:XXX:Doc:Sequencing


name: IDH1 & IDH2 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Borrelia recurrentis:PrThr:Pt:XXX:Ord:Organism specific culture


name: Corynebacterium ulcerans:PrThr:Pt:XXX:Ord:Organism specific culture


name: Dengue virus Ab.IgM^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Yersinia pseudotuberculosis 1 Ab:PrThr:Pt:Stool:Ord


name: HL7 Standardization Medication Profile (SMP)


name: Transfer to same level Intensive Care Unit


name: Transfer to more specialized Intensive Care Unit ( ICU)


name: Thorater percutaneous ventricular assist device (PVAD)


name: CentriMag acute mechanical circulatory support system


name: Tandem Heart Percutaneous Ventricular Assist Device


name: Go to any other place or event not mentioned


name: History and physical note:Find:Pt:{Setting}:Doc:Rapid response team


name: Surgical operation note:Find:Pt:{Setting}:Doc:Clinical cardiac electrophysiology


name: Consultation note:Find:Pt:Outpatient:Doc:Physical medicine and rehab


name: Preoperative evaluation and management note:Find:Pt:{Setting}:Doc:General medicine


name: Study observation^W fluorescein IV:Find:Pt:Ocular fundus:Nom:Angiography


name: Cosmetic product listing:Find:Pt:^FDA package insert:Nar


name: Cosmetic facility registration:Find:Pt:^FDA package insert:Nar


name: Comprehensive foot screening report:Find:Pt:^Patient:Doc


name: Retinal eye screening report:Find:Pt:^Patient:Doc


name: Brief interview for mental status:-:RptPeriod:^Patient:-:CMS Assessment


name: Repetition of three words:Num:RptPeriod:^Patient:Ord:CMS Assessment


name: Temporal orientation - current year:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Temporal orientation - current month:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Recall - sock:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Recall - blue:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Recall - bed:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Temporal orientation (orientation to year, month, and day):-:RptPeriod:^Patient:-:CMS Assessment


name: Temporal orientation - current day of the week:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Brief interview for mental status - summary score:Score:RptPeriod:^Patient:Qn:CMS Assessment


name: Mood interview total severity score:Score:RptPeriod:^Patient:Qn:CMS Assessment


name: Staff assessment of resident mood (PHQ-9-OV):-:RptPeriod:^Patient:-:CMS Assessment


name: Staff assessment of resident mood total severity score:Score:RptPeriod:^Patient:Qn:CMS Assessment


name: How often do you need to have someone help you when you read instructions, pamphlets, or other written material from your doctor or pharmacy:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Mental health directive form:Find:Pt:{Setting}:Doc:Mental health


name: Annual evaluation note:Find:Pt:{Setting}:Doc:Mental health


name: Note:Find:Pt:Outpatient:Doc:Child and adolescent psychiatry


name: Patient state index:Score:Pt:Cerebral cortex:Qn:EEG


name: Study observation:Find:Pt:Lower GI tract:Nar:CT


name: Pneumonia probability:Likelihood:Pt:^Patient:Qn:Artificial intelligence based calculation


name: Medication Management Note:Find:Pt:{Setting}:Doc:Bone marrow transplant


name: Medication Management Note:Find:Pt:{Setting}:Doc:Cardiovascular disease


name: Medication Management Note:Find:Pt:{Setting}:Doc:Critical Care Medicine


name: Medication Management Note:Find:Pt:{Setting}:Doc:Emergency medicine


name: Medication Management Note:Find:Pt:{Setting}:Doc:Geriatric medicine


name: Medication Management Note:Find:Pt:{Setting}:Doc:Infectious disease


name: Medication Management Note:Find:Pt:Long term care facility:Doc


name: Views^W contrast IT:Find:Pt:Abdomen>Spine.lumbar & Pelvis>Sacrum:Doc:RF


name: Guidance for removal of foreign body:Find:Pt:Chest>Esophagus:Doc:RF


name: Views^W contrast via nephrostomy tube:Find:Pt:Abdomen>Kidney:Doc:RF


name: Views^W contrast retrograde via urethra:Find:Pt:Pelvis>Urethra:Doc:RF


name: Guidance for angioplasty^W contrast:Find:Pt:Extremity>Extremity vessels.bilateral:Doc:RF.angio


name: Guidance for angioplasty^W contrast:Find:Pt:Extremity>Extremity vessels.left:Doc:RF.angio


name: Guidance for angioplasty^W contrast:Find:Pt:Extremity>Extremity vessels.right:Doc:RF.angio


name: Views^W contrast IA:Find:Pt:Head+Neck>Carotid artery.internal.bilateral:Doc:RF.angio


name: Views^W contrast IA:Find:Pt:Head+Neck>Vertebral vessels.left:Doc:RF.angio


name: Views^W contrast IA:Find:Pt:Head+Neck>Vertebral vessels.right:Doc:RF.angio


name: Views GE 2 && Views:Find:Pt:Chest:Doc:XR && RF


name: Multisection^W contrast PO+W contrast IV:Find:Pt:Abdomen+Pelvis:Doc:CT


name: Multisection^W contrast PO+W contrast IV:Find:Pt:Abdomen:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Head>Facial bones:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Abdomen>Kidney & Abdomen+Pelvis>Ureter & Pelvis>Urinary bladder:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Head>Sella turcica+Orbit:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.bilateral>Shoulder:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Lower extremity.bilateral>Lower leg:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.bilateral>Lower leg:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Head>Sella turcica+Orbit:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Head>Sella turcica+Orbit.bilateral:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Head>Sella turcica+Orbit.bilateral:Doc:CT


name: Multisection^W contrast PO+W contrast IV:Find:Pt:Pelvis:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Upper extremity.bilateral>Forearm:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.bilateral>Forearm:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.bilateral>Ankle:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Head>Mastoid:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.bilateral>Foot:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.bilateral>Wrist:Doc:CT


name: Views screening for implant:Find:Pt:Breast.left:Doc:MG


name: Views screening for implant:Find:Pt:Breast.right:Doc:MG


name: View^W contrast intra duct:Find:Pt:Breast>Breast duct.bilateral:Doc:MG


name: Guidance for needle localization:Find:Pt:Breast:Doc:MG


name: Views screening for implant:Find:Pt:Breast:Doc:MG


name: Views diagnostic for implant:Find:Pt:Breast:Doc:MG


name: Multisection limited:Find:Pt:Chest>Aorta.thoracic & Abdomen>Aorta.abdominal:Doc:US.doppler


name: Multisection:Find:Pt:Chest>Aorta.thoracic & Abdomen>Aorta.abdominal+Vena cava.inferior:Doc:US.doppler


name: Multisection limited:Find:Pt:Chest>Aorta.thoracic & Abdomen>Aorta.abdominal+Vena cava.inferior:Doc:US.doppler


name: Multisection limited:Find:Pt:Lower extremity.left>Lower extremity vein:Doc:US


name: Multisection limited:Find:Pt:Lower extremity.right>Lower extremity vein:Doc:US


name: Multisection limited:Find:Pt:Lower extremity.left>Lower extremity artery:Doc:US


name: Multisection limited:Find:Pt:Lower extremity.right>Lower extremity artery:Doc:US


name: Multisection limited:Find:Pt:Lower extremity.left>Lower extremity artery:Doc:US.doppler


name: Multisection limited:Find:Pt:Lower extremity.right>Lower extremity artery:Doc:US.doppler


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 5.1:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 5.1:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 5.1:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 5.1:-:RptPeriod:^Patient:-:CMS Assessment


name: Rehabilitation progress note:Find:Pt:{Setting}:Doc:Cardiovascular disease


name: Ectopic pregnancy &or abortion:Num:Pt:^Patient:Qn:Reported


name: Information to tell doctors if you have a sudden injury or illness with a good chance of recovery:Find:Pt:^Patient:Nar:Reported


name: Information to tell the medical team if you stop breathing or your heart stops beating:Find:Pt:^Patient:Nar:Reported


name: CMS - Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 4.2:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.2, LCDS v5.1, MDS v1.19.1 - Functional abilities - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.2, LCDS v5.1, MDS v1.19.1 - Functional abilities - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: Multisection for pregnancy+third trimester:Find:Pt:Pelvis+^Fetus:Nom:US


name: Information to tell doctors if you experience failing health with a low chance of recovery:Find:Pt:^Patient:Nar:Reported


name: Multisection for pregnancy+second trimester:Find:Pt:Pelvis+^Fetus:Nom:US


name: Intensive Care Unit {ICU} specialty destination:Type:Pt:^Patient:Nominal


name: Multisection^W contrast IV && Multisection^WO & W contrast IV:Find:Pt:Head && Neck:Doc:CT.angio && CT.angio


name: Cosmetic facility registration:Find:Pt:^FDA product label:Nar


name: Cosmetic facility registration-amendment:Find:Pt:^FDA product label:Nar


name: Cosmetic facility registration-abbreviated renewal:Find:Pt:^FDA product label:Nar


name: Cosmetic facility registration-cancellation:Find:Pt:^FDA product label:Nar


name: Cosmetic facility registration-biennial renewal:Find:Pt:^FDA product label:Nar


name: Cosmetic-abbreviated renewal:Find:Pt:^FDA product label:Nar


name: Animal drug for further processing:Find:Pt:^FDA product label:Nar


name: Alive and without mechanical ventilation:Score:4W:^Patient:Qn:Reported


name: Alive and without mechanical ventilation:Score:2M:^Patient:Qn:Reported


name: Alive and without mechanical ventilation:Score:3W:^Patient:Qn:Reported


name: History and physical note:Find:Pt:{Setting}:Doc:Vascular Access


name: Group counseling note:Find:Pt:{Setting}:Doc:Child Life


name: View for salivary calculus:Find:Pt:Head>Salivary gland:Doc:XR


name: View for salivary calculus:Find:Pt:Head>Salivary gland.bilateral:Doc:XR


name: View for salivary calculus:Find:Pt:Head>Salivary gland.right:Doc:XR


name: View for salivary calculus:Find:Pt:Head>Salivary gland.left:Doc:XR


name: Feeling down, depressed, irritable, or hopeless in last 2W:Find:2W:^Patient:Ord:Reported.PHQ


name: Little interest or pleasure in doing things in last 2W:Find:2W:^Patient:Ord:Reported.PHQ


name: Poor appetite, weight loss, or overeating in last 2W:Find:2W:^Patient:Ord:Reported.PHQ


name: Trouble concentrating on things like school work, reading, or watching TV in last 2W:Find:2W:^Patient:Ord:Reported.PHQ


name: Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn:US.2D.A2C+Calculated by biplane method


name: Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn:US.2D.A3C+Calculated by biplane method


name: Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn:US.2D.A4C+Calculed by biplane method


name: Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn:US.3D.A2C+Calculated by biplane method


name: Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn:US.3D.A3C+Calculated by biplane method


name: Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn:US.3D.A4C+Calculated by biplane method


name: Longitudinal strain.max:LenRto:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by triplane method


name: End-systolic volume/Body surface area:ArVol:Pt:Heart.ventricle.left:Qn:US.2D.A2C+Calculated by biplane area-length method


name: Orifice area/Body surface area:ArArea:Pt:Aortic valve:Qn:US.2D


name: Maternal condition that affected the fetus:Find:Pt:^Mother:Nom


name: Secondary cause of death:Find:Pt:^Fetus:Nom


name: Disease onset to death interval:Time:Pt:^Patient:Qn


name: Multisection for pregnancy+first trimester:Find:Pt:Pelvis+^Fetus:Nom:US


name: Patient generated medication list:ID:Episode:Pharmacy:Nom


name: Medication list for public health &or CDC reporting:ID:Episode:Pharmacy:Nom


name: Multisection transesophageal for congenital disease^W agitated saline IV:Find:Pt:Chest>Heart:Doc:US


name: Views screening for diabetic retinopathy:Find:Pt:Eye.left:Doc:{Imaging modality}


name: Views screening for diabetic retinopathy:Find:Pt:Eye.right:Doc:{Imaging modality}


name: Views^post radioactive seed localization:Find:Pt:Breast.left:Doc:MG.stereotactic


name: Views^post radioactive seed localization:Find:Pt:Breast.right:Doc:MG.stereotactic


name: Duration description of condition episode:Find:Pt:^Patient:Ord:Reported


name: US.doppler|Lower extremity artery|Multisection limited|Laterality:ANY


name: US|Lower extremity artery|Multisection limited|Laterality:ANY


name: US|Lower extremity vein|Multisection limited|Laterality:ANY


name: MG.stereotactic|Breast|Views^post radioactive seed localization|Laterality:ANY


name: MG|Breast|Views screening for implant|Laterality:ANY


name: 10 minutes post dose gonadotropin releasing hormone


name: Platelet aggregation collagen induced 2 ug/mL


name: Platelet aggregation.adenosine diphosphate induced ATP secretion^2 umol/L


name: Cells.CD34 recipient derived/Cells.CD34^post stem cell transplantation


name: Views^post radioactive seed localization


name: Multisection transesophageal for congenital disease^W agitated saline IV


name: US.2D.A2C+Calculated by biplane area-length method


name: US.3D.A4C+Calculated by biplane area-length method


name: US.2D.A4C+Calculated by biplane area-length method


name: US.2D+Calculated by average triplane method


name: Artificial intelligence based calculation


name: Tick-borne Ab panel | Serum | Microbiology


name: Amoxicillin+Clavulanate | Isolate.UTI | Antibiotic susceptibilities


name: Aldosterone/Renin | Serum or Plasma | Chemistry - non-challenge


name: Creatine/Creatinine | DBS | Chemistry - non-challenge


name: Guanidinoacetate/Creatinine | DBS | Chemistry - non-challenge


name: Mucopolysaccharidosis type II newborn screen interpretation | DBS | Chemistry - non-challenge


name: Mucopolysaccharidosis type II comment | DBS | Chemistry - non-challenge


name: Iohexol disappearance panel | Urine and Serum or Plasma | Chemistry Panels


name: Immunoglobulins and heavy-light chain panel | Serum or Plasma | Chemistry Panels


name: External Steroid panel | Serum or Plasma | Chemistry Panels


name: Eszopiclone and Zopiclone | Urine | Drug toxicology


name: Ethanol cutoff | Exhaled gas | Drug toxicology


name: Other cells/100 leukocytes | Bronchoalveolar lavage | Hematology and Cell counts


name: Coagulation surface induced.lupus sensitive.buffer (LA control) | Platelet poor plasma | Coagulation


name: Horse dander IgE panel | Serum or Plasma | Allergy Panels


name: Cat epithelium IgE panel | Serum or Plasma | Allergy Panels


name: Dog dander IgE panel | Serum or Plasma | Allergy Panels


name: Direct antiglobulin test.polyspecific reagent | Fetus | Blood bank


name: Direct antiglobulin test.polyspecific reagent | Fetus | Red Blood Cells | Blood bank


name: ABO group and Rh Type and Atypical Ab Panel


name: ABO group and Rh Type and Atypical Ab Panel | Serum, Plasma or Blood | Blood Bank Panels


name: Cells.CD19/100 lymphocytes | Blood | Cell markers


name: Lymphocytes.lambda/100 lymphocytes | Bone marrow | Cell markers


name: Spermatozoa.viable/100 spermatozoa | Urine | Fertility testing


name: Spermatozoa.nonprogressive/100 spermatozoa | Urine | Fertility testing


name: Additional treatment | Urine | Fertility testing


name: Erythrocytosis multigene analysis | XXX | Molecular pathology


name: Erythrocytosis focused multigene analysis | XXX | Molecular pathology


name: EBV Lymphoproliferation multigene analysis | Blood or Tissue | Molecular pathology


name: Dysregulation autoimmune multigene analysis | XXX | Molecular pathology


name: Dyserythropoietic anemia multigene analysis | XXX | Molecular pathology


name: Distal weakness multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary spastic paraplegia multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary sensory neuropathy multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary Motor Neuropathy multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary motor and sensory neuropathy multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary emery dreifuss multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary congenital myasthenic syndrome multigene analysis | Blood or Tissue | Molecular pathology


name: HMEP-Hemiplegic migraine multigene analysis | Blood or Tissue | Molecular pathology


name: Hyper igE syndrome multigene analysis | XXX | Molecular pathology


name: Histiocytic neoplasm multigene analysis | Blood or Tissue | Molecular pathology


name: Plasma cell myeloma multigene analysis | Bone marrow | Molecular pathology


name: T cell lymphoma multigene analysis | Blood or Tissue | Molecular pathology


name: RBC membrane multigene analysis | XXX | Molecular pathology


name: CTNNB1 gene targeted mutation analysis | Tumor | Molecular pathology


name: CYB5 and CYB5 Reductase multigene analysis | XXX | Molecular pathology


name: KRAS Somatic mutation analysis | Tumor | Mutations


name: Viral Susceptibility multigene analysis | XXX | Molecular pathology


name: Autoimmune lymphoproliferative syndrome multigene analysis | XXX | Molecular pathology


name: Breast Cancer recurrence risk multigene analysis | Tiss | Molecular pathology


name: B cell non hodgkin Lymphoma multigene analysis | Blood or Tissue | Molecular pathology


name: Chronic and low grade B cell lymphoid neoplasm multigene analysis | Blood or Tissue | Molecular pathology


name: Metagenomic DNA and RNA Sequencing | Cerebral spinal fluid | Molecular pathology


name: Color | Spun Pericardial fluid | Specimen information


name: Color | Spun Peritoneal fluid | Specimen information


name: Color | Spun Pleural fluid | Specimen information


name: Cell growth | Amniocytes | Specimen information


name: Cell growth | Chorionic villus sample | Specimen information


name: Discharge instructions | Outpatient | Document ontology


name: Instructions | Outpatient | Document ontology


name: Body temperature | Groin | Specific body temperature


name: End-systolic volume/Body surface area | Heart ventricle - left | Specific hemodynamics


name: US.3D.A2C+Calculated by biplane area-length method


name: Medication Reference Terminology, 2024_03_04


name: Czech translation of the Medical Subject Headings, 2024


name: Thesaurus Biomedical Francais/Anglais (French translation of the Medical Subject Headings), 2024


name: Polish translation of the Medical Subject Headings, 2024


name: Descritores em Ciencias da Saude (Portuguese translation of the Medical Subject Headings), 2024


name: Russian translation of the Medical Subject Headings, 2024


name: Descritores en Ciencias de la Salud (Spanish translation of the Medical Subject Headings), 2024